Contact Molecules for Homologous Proteins


[Full Bars]

[SiteTable]


Summary Bars[30 %]


[Back to Search Page]

[Back to HOMCOS]

[SupCon3D]

[help]
seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]
[show] [download] [help]
PID QueryLength Homolgous Sequence in PDB UniProt Query TITLE
9058 422 256 P59595(NCAP_SARS) RecName: Full=Nucleoprotein ;AltName: Full=Nucleocapsid protein ; Short=NC ; Short=Protein N ;
QUERYSEQ
MSDNGPQSNQRSAPRITFGGPTDSTDNNQNGGRNGARPKQRRPQGLPNNTASWFTALTQHGKEELRFPRGQGVPINTNSGPDDQIGYYRRATRRVRGGDGKMKELSPRWYFYYLGTGPEASLPYGANKEGIVWVATEGALNTPKDHIGTR
NPNNNAATVLQLPQGTTLPKGFYAEGSRGGSQASSRSSSRSRGNSRNSTPGSSRGNSPARMASGGGETALALLLLDRLNQLESKVSGKGQQQQGQTVTKKSAAEASKKPRQKRTATKQYNVTQAFGRRGPEQTQGNFGDQDLIRQGTDYK
HWPQIAQFAPSASAFFGMSRIGMEVTPSGTWLTYHGAIKLDDKDPQFKDNVILLNKHIDAYKTFPPTEPKKDKKKKTDEAQPLPQRQKKQPTVTLLPAADMDDFSRQLQNSMSGASADSTQA
[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

UniProt Feature Tables [P59595(NCAP_SARS)]

422
region name description
1-422 CHAIN /note="Nucleoprotein" /id="PRO_0000106003"
49-176 DOMAIN /note="CoV N NTD"
248-365 DOMAIN /note="CoV N CTD"
1-52 REGION /note="Disordered"
42-187 REGION /note="RNA-binding"
45-181 REGION /note="RNA-binding"
167-214 REGION /note="Disordered"
177-204 REGION /note="SR region"
234-287 REGION /note="Disordered"
259-362 REGION /note="Dimerization"
362-422 REGION /note="Disordered"
1-35 COMPBIAS /note="Polar residues"
178-209 COMPBIAS /note="Polar residues"
234-252 COMPBIAS /note="Polar residues"
265-287 COMPBIAS /note="Polar residues"
363-383 COMPBIAS /note="Basic and acidic residues"
404-422 COMPBIAS /note="Polar residues"
93-93 BINDING /ligand="RNA" /ligand_id="ChEBI:CHEBI:33697"
108-108 BINDING /ligand="RNA" /ligand_id="ChEBI:CHEBI:33697"
150-150 BINDING /ligand="RNA" /ligand_id="ChEBI:CHEBI:33697"
1-422 DISORDER predicted by DISOPRED

MONOMER
422
pdb_id a1 identity[%]2 description
8fg2 B 91.2 NCAP_SARS2 Nucleoprotein
1.a1:asym_id for the homologue. 2.identity[%]2:sequence identity between the query and the homologue.
HETERO
422 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7n0i[8] H Single-domain antibody E2[136 aa] A 90.0
/95.8
10
/10
NCAP_SARS2 Nucleoprotein
7ylb[8] C NC2[84 aa] A 92.3
/95.4
13
/13
NCAP_SARS2 Nucleoprotein
7r98[3] D Nanobody B6[129 aa] A 100.0
/92.4
14
/14
NCAP_SARS2 Nucleoprotein
7n3d[1] A S24-1564 Fab heavy chain[223 aa] C 100.0
/92.7
12
/12
NCAP_SARS2 Nucleoprotein
7n3d[1] B S24-1564 Fab light chain[213 aa] C 87.5
/92.7
8
/8
NCAP_SARS2 Nucleoprotein
7sue[2] A S24-188 Fab Light chain[212 aa] E 100.0
/92.2
5
/5
NCAP_SARS2 Nucleoprotein
7sue[2] B S24-188 Fab Heavy chain[227 aa] E 100.0
/92.2
8
/8
NCAP_SARS2 Nucleoprotein
7sue[2] G S24-188 Fab Light chain[109 aa] K 100.0
/93.0
5
/5
NCAP_SARS2 Nucleoprotein
7sue[2] H S24-188 Fab Heavy chain[129 aa] K 100.0
/93.0
7
/7
NCAP_SARS2 Nucleoprotein
7n3c[1] A S24-202 Fab heavy chain[226 aa] C 100.0
/92.1
11
/11
NCAP_SARS2 Nucleoprotein
7n0r[2] C Single-domain antibody C2[123 aa] A 88.2
/92.1
17
/17
NCAP_SARS2 Nucleoprotein
7n3c[2] B S24-202 Fab light chain[214 aa] C 80.0
/92.1
5
/5
NCAP_SARS2 Nucleoprotein
7str[1] B Fab S24-1063, Heavy chain[222 aa] C 100.0
/92.1
11
/11
NCAP_SARS2 Nucleoprotein
7cr5[1] B monoclonal antibody chain H[216 aa] A 100.0
/92.0
7
/7
NCAP_SARS2 Nucleoprotein
7cr5[1] C monoclonal antibody chain L[213 aa] A 93.3
/92.0
15
/15
NCAP_SARS2 Nucleoprotein
7pku[2] A A0A6M4N019_SARS2 3C-like proteinase[96 aa] B 94.4
/89.0
18
/18
A0A6G9KDV1_SARS2 Nucleoprotein
7wzo[1] C R1A_SARS2 nsp3[110 aa] A 100.0
/92.0
10
/10
NCAP_SARS2 Nucleoprotein
7sts[2] E Fab S24-1379, heavy chain[210 aa] C 83.3
/92.8
6
/6
NCAP_SARS2 Nucleoprotein
7sts[2] F Fab S24-1379, light chain[212 aa] C 83.3
/92.8
6
/6
NCAP_SARS2 Nucleoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
NUCLEOTIDE
422 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7act[1] B ssRNA A 85.7
/92.7
28
/28
NCAP_SARS2 Nucleoprotein
7acs[1] B RNA (5'-R(P*CP*AP*CP*UP*GP*AP*C)-3') A 60.0
/92.0
5
/5
NCAP_SARS2 Nucleoprotein
7xwz[1] C RNA (5'-R(*CP*AP*CP*UP*GP*AP*C)-3') A 50.0
/92.0
2
/2
NCAP_SARS2 Nucleoprotein
7acs[1] C RNA (5'-R(P*GP*UP*CP*AP*GP*UP*G)-3') A 81.8
/92.0
11
/11
NCAP_SARS2 Nucleoprotein
7xwz[2] D RNA (5'-R(P*GP*UP*CP*AP*GP*UP*G)-3') A 100.0
/92.0
8
/8
NCAP_SARS2 Nucleoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
COMPOUND
422 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7o35[3] E GTP
GUANOSINE-5'-TRIPHOSPHATE[32 atoms]
C 100.0
/95.5
4
/4
NCAP_SARS2 Nucleoprotein
7o35[3] E GTP
GUANOSINE-5'-TRIPHOSPHATE[32 atoms]
D 100.0
/95.4
4
/4
NCAP_SARS2 Nucleoprotein
4lm9[1] B 5GP
GUANOSINE-5'-MONOPHOSPHATE[24 atoms]
A 80.0
/48.8
10
/14
Q6SA23_CVHOC Nucleoprotein
7xxk[3] H 5GP
GUANOSINE-5'-MONOPHOSPHATE[24 atoms]
A 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[3] I 5GP
GUANOSINE-5'-MONOPHOSPHATE[24 atoms]
A 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7uxz[1] G GKP
(2R,3R)-2,3-bis{[(2E)-3-(3,4-dihydroxyphenyl)prop-..
A 100.0
/95.4
8
/8
NCAP_SARS2 Nucleoprotein
7xxk[1] R GUN
GUANINE[11 atoms]
C 100.0
/95.3
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[1] R GUN
GUANINE[11 atoms]
D 100.0
/95.4
2
/2
NCAP_SARS2 Nucleoprotein
7xxk[1] FA GMP
GUANOSINE[20 atoms]
E 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[1] FA GMP
GUANOSINE[20 atoms]
F 100.0
/95.3
3
/3
NCAP_SARS2 Nucleoprotein
8j6x[1] E U2H
~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-y..
A 100.0
/92.1
2
/2
NCAP_SARS2 Nucleoprotein
8j6x[1] E U2H
~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-y..
B 100.0
/92.2
2
/2
NCAP_SARS2 Nucleoprotein
8j6x[1] E U2H
~{N}-methyl-~{N}-[(5-phenylmethoxy-1~{H}-indol-3-y..
D 100.0
/92.1
4
/4
NCAP_SARS2 Nucleoprotein
6kl6[1] E DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth..
B 83.3
/60.3
6
/6
A0A0D3MU65_9BETC Nucleoprotein
6kl6[1] E DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth..
D 57.1
/62.2
7
/7
A0A0D3MU65_9BETC Nucleoprotein
8iv3[1] E DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth..
A 66.7
/92.1
3
/3
NCAP_SARS2 Nucleoprotein
8iv3[1] E DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth..
B 100.0
/92.2
1
/1
NCAP_SARS2 Nucleoprotein
8iv3[1] E DJU
N,N-dimethyl-1-(5-phenylmethoxy-1H-indol-3-yl)meth..
D 100.0
/92.1
4
/4
NCAP_SARS2 Nucleoprotein
6kl5[1] E DJO
(phenylmethyl) (2S)-2-(hydroxymethyl)-2,3-dihydroi..
A 75.0
/60.5
4
/4
A0A0D3MU65_9BETC Nucleoprotein
6kl5[1] E DJO
(phenylmethyl) (2S)-2-(hydroxymethyl)-2,3-dihydroi..
C 50.0
/62.1
4
/4
A0A0D3MU65_9BETC Nucleoprotein
7dyd[1] E EY3
5-propan-2-yloxy-1H-indole[13 atoms]
B 100.0
/59.1
1
/1
A0A2I2MQD0_9BETC Nucleoprotein
7dyd[1] E EY3
5-propan-2-yloxy-1H-indole[13 atoms]
D 83.3
/61.8
6
/6
A0A2I2MQD0_9BETC Nucleoprotein
6lz8[1] E EY9
5-(2-methoxyethoxy)-1H-indole[14 atoms]
C 100.0
/59.1
2
/2
A0A2I2MQD0_9BETC Nucleoprotein
6lz8[1] E EY9
5-(2-methoxyethoxy)-1H-indole[14 atoms]
D 100.0
/61.6
3
/3
A0A2I2MQD0_9BETC Nucleoprotein
6lnn[1] E EJC
5-propoxy-1H-indole[13 atoms]
B 100.0
/60.0
1
/1
A0A2I2MQD0_9BETC Nucleoprotein
6lnn[1] E EJC
5-propoxy-1H-indole[13 atoms]
D 100.0
/61.3
5
/5
A0A2I2MQD0_9BETC Nucleoprotein
6lz6[1] E EY6
5-(2-fluoranylethoxy)-1H-indole[13 atoms]
B 100.0
/59.1
1
/1
A0A2I2MQD0_9BETC Nucleoprotein
6lz6[1] E EY6
5-(2-fluoranylethoxy)-1H-indole[13 atoms]
D 100.0
/60.9
7
/7
A0A2I2MQD0_9BETC Nucleoprotein
4li4[1] B AMP
ADENOSINE MONOPHOSPHATE[23 atoms]
A 80.0
/49.2
10
/14
Q6SA23_CVHOC Nucleoprotein
4lm7[1] B U5P
URIDINE-5'-MONOPHOSPHATE[21 atoms]
A 80.0
/49.2
10
/14
Q6SA23_CVHOC Nucleoprotein
4lmt[1] B CQD
6-chloro-7-{[2-(morpholin-4-yl)ethyl]amino}quinoli..
A 83.3
/48.8
6
/10
Q6SA23_CVHOC Nucleoprotein
4lmc[1] B C5P
CYTIDINE-5'-MONOPHOSPHATE[21 atoms]
A 88.9
/48.8
9
/13
Q6SA23_CVHOC Nucleoprotein
4kxj[1] B P34
N~2~,N~2~-DIMETHYL-N~1~-(6-OXO-5,6-DIHYDROPHENANTH..
A 50.0
/48.4
6
/10
Q6SA23_CVHOC Nucleoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
METAL
422 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7n0i[1] N MG
MAGNESIUM ION[1 atoms]
D 100.0
/95.8
3
/3
NCAP_SARS2 Nucleoprotein
6g13[2] I CL
CHLORIDE ION[1 atoms]
B 50.0
/54.2
2
/2
A0A0D3MU51_9BETC Nucleoprotein
6vyo[13] F CL
CHLORIDE ION[1 atoms]
A 100.0
/91.9
1
/1
NCAP_SARS2 Nucleoprotein
6vyo[4] I CL
CHLORIDE ION[1 atoms]
A 66.7
/91.9
3
/3
NCAP_SARS2 Nucleoprotein
6wji[6] G CL
CHLORIDE ION[1 atoms]
A 100.0
/95.4
1
/1
NCAP_SARS2 Nucleoprotein
6wji[4] H CL
CHLORIDE ION[1 atoms]
A 100.0
/95.4
1
/1
NCAP_SARS2 Nucleoprotein
7n3d[1] O CL
CHLORIDE ION[1 atoms]
C 100.0
/92.7
2
/2
NCAP_SARS2 Nucleoprotein
7n3d[1] P CL
CHLORIDE ION[1 atoms]
C 100.0
/92.7
2
/2
NCAP_SARS2 Nucleoprotein
7uxz[1] L CL
CHLORIDE ION[1 atoms]
E 100.0
/95.4
1
/1
NCAP_SARS2 Nucleoprotein
7xxk[1] O CL
CHLORIDE ION[1 atoms]
B 100.0
/95.3
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[1] P CL
CHLORIDE ION[1 atoms]
B 100.0
/95.3
1
/1
NCAP_SARS2 Nucleoprotein
7xxk[1] V CL
CHLORIDE ION[1 atoms]
C 100.0
/95.3
2
/2
NCAP_SARS2 Nucleoprotein
7xxk[1] X CL
CHLORIDE ION[1 atoms]
C 100.0
/95.3
2
/2
NCAP_SARS2 Nucleoprotein
7xxk[2] Y CL
CHLORIDE ION[1 atoms]
C 100.0
/95.3
2
/2
NCAP_SARS2 Nucleoprotein
7xxk[1] EA CL
CHLORIDE ION[1 atoms]
E 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[1] IA CL
CHLORIDE ION[1 atoms]
F 100.0
/95.3
1
/1
NCAP_SARS2 Nucleoprotein
7uxz[3] J NA
SODIUM ION[1 atoms]
A 100.0
/95.4
2
/2
NCAP_SARS2 Nucleoprotein
7xxk[5] J K
POTASSIUM ION[1 atoms]
A 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[2] K K
POTASSIUM ION[1 atoms]
A 66.7
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[1] L K
POTASSIUM ION[1 atoms]
A 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7xxk[1] M K
POTASSIUM ION[1 atoms]
A 100.0
/95.4
2
/2
NCAP_SARS2 Nucleoprotein
7xxk[5] N K
POTASSIUM ION[1 atoms]
A 100.0
/95.4
1
/1
NCAP_SARS2 Nucleoprotein
6vyo[12] H ZN
ZINC ION[1 atoms]
A 66.7
/91.9
3
/3
NCAP_SARS2 Nucleoprotein
6vyo[8] J ZN
ZINC ION[1 atoms]
A 100.0
/91.9
1
/1
NCAP_SARS2 Nucleoprotein
7cr5[1] D ZN
ZINC ION[1 atoms]
A 100.0
/92.0
1
/1
NCAP_SARS2 Nucleoprotein
7xx1[4] J ZN
ZINC ION[1 atoms]
A 100.0
/92.0
1
/1
NCAP_SARS2 Nucleoprotein
7n3c[1] T IOD
IODIDE ION[1 atoms]
C 66.7
/92.1
3
/3
NCAP_SARS2 Nucleoprotein
7n3c[1] U IOD
IODIDE ION[1 atoms]
C 100.0
/92.1
2
/2
NCAP_SARS2 Nucleoprotein
7n3c[1] V IOD
IODIDE ION[1 atoms]
C 100.0
/92.1
1
/1
NCAP_SARS2 Nucleoprotein
7n3c[1] W IOD
IODIDE ION[1 atoms]
C 100.0
/92.1
4
/4
NCAP_SARS2 Nucleoprotein
7n3c[1] X IOD
IODIDE ION[1 atoms]
C 100.0
/92.1
2
/2
NCAP_SARS2 Nucleoprotein
4ud1[3] F NH4
AMMONIUM ION[1 atoms]
A 0.0
/58.3
2
/2
T2B9R0_9BETC N PROTEIN
4ud1[1] J NH4
AMMONIUM ION[1 atoms]
C 100.0
/58.3
1
/1
T2B9R0_9BETC N PROTEIN
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
HOMO
422 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
2cjr[114] B NCAP_CVHSA NUCLEOCAPSID PROTEIN[113 aa] A 100.0
/100.0
52
/52
NCAP_CVHSA NUCLEOCAPSID PROTEIN
2gib[2] A NCAP_CVHSA Nucleocapsid protein[97 aa] A 100.0
/100.0
8
/8
NCAP_CVHSA Nucleocapsid protein
2gib[2] A NCAP_CVHSA Nucleocapsid protein[97 aa] A 100.0
/100.0
6
/6
NCAP_CVHSA Nucleocapsid protein
2gib[2] B NCAP_CVHSA Nucleocapsid protein[96 aa] A 100.0
/100.0
1
/1
NCAP_CVHSA Nucleocapsid protein
2gib[2] A NCAP_CVHSA Nucleocapsid protein[97 aa] B 100.0
/100.0
3
/3
NCAP_CVHSA Nucleocapsid protein
7f2e[1] F NCAP_SARS2 Nucleoprotein[97 aa] E 97.7
/94.8
43
/43
NCAP_SARS2 Nucleoprotein
7f2e[1] L NCAP_SARS2 Nucleoprotein[92 aa] K 97.6
/94.8
41
/41
NCAP_SARS2 Nucleoprotein
6wkp[1] A NCAP_SARS2 Nucleoprotein[103 aa] B 87.5
/92.3
8
/8
NCAP_SARS2 Nucleoprotein
6wkp[1] A NCAP_SARS2 Nucleoprotein[103 aa] D 100.0
/92.2
6
/6
NCAP_SARS2 Nucleoprotein
6vyo[121] B NCAP_SARS2 Nucleoprotein[125 aa] A 91.7
/91.9
12
/12
NCAP_SARS2 Nucleoprotein
6vyo[11] D NCAP_SARS2 Nucleoprotein[125 aa] A 88.9
/91.9
9
/9
NCAP_SARS2 Nucleoprotein
7xx1[4] D NCAP_SARS2 Nucleoprotein[119 aa] A 87.5
/92.0
8
/8
NCAP_SARS2 Nucleoprotein
8iv3[2] B NCAP_SARS2 Nucleoprotein[128 aa] A 83.3
/92.1
6
/6
NCAP_SARS2 Nucleoprotein
8iv3[2] C NCAP_SARS2 Nucleoprotein[128 aa] A 90.0
/92.1
10
/10
NCAP_SARS2 Nucleoprotein
8iv3[2] D NCAP_SARS2 Nucleoprotein[126 aa] A 90.9
/92.1
11
/11
NCAP_SARS2 Nucleoprotein
8iv3[4] A NCAP_SARS2 Nucleoprotein[126 aa] B 100.0
/92.2
10
/10
NCAP_SARS2 Nucleoprotein
8iv3[2] C NCAP_SARS2 Nucleoprotein[128 aa] B 100.0
/92.2
6
/6
NCAP_SARS2 Nucleoprotein
8iv3[2] D NCAP_SARS2 Nucleoprotein[126 aa] B 100.0
/92.2
4
/4
NCAP_SARS2 Nucleoprotein
8iv3[4] A NCAP_SARS2 Nucleoprotein[126 aa] C 87.5
/92.2
8
/8
NCAP_SARS2 Nucleoprotein
8x1h[48] A NCAP_SARS2 Nucleoprotein[128 aa] A 92.2
/92.2
128
/128
NCAP_SARS2 Nucleoprotein
8x1h[16] A NCAP_SARS2 Nucleoprotein[128 aa] B 100.0
/92.3
13
/13
NCAP_SARS2 Nucleoprotein
8x1h[16] D NCAP_SARS2 Nucleoprotein[122 aa] C 100.0
/92.1
1
/1
NCAP_SARS2 Nucleoprotein
8x1h[16] C NCAP_SARS2 Nucleoprotein[127 aa] D 100.0
/91.8
1
/1
NCAP_SARS2 Nucleoprotein
6kl2[12] C A0A0D3MU65_9BETC Nucleoprotein[104 aa] A 71.4
/61.4
7
/9
A0A0D3MU65_9BETC Nucleoprotein
6lnn[16] C A0A2I2MQD0_9BETC Nucleoprotein[114 aa] A 77.8
/58.7
9
/12
A0A2I2MQD0_9BETC Nucleoprotein
6g13[4] C A0A0D3MU51_9BETC Nucleoprotein[113 aa] A 63.0
/54.3
54
/55
A0A0D3MU51_9BETC Nucleoprotein
5n4k[2] B NCAP_CVHNL Nucleoprotein[129 aa] A 33.3
/45.5
12
/22
NCAP_CVHNL Nucleoprotein
2gec[1] B NCAP_IBVG Nucleocapsid protein[139 aa] A 27.8
/41.3
18
/18
NCAP_IBVG Nucleocapsid protein
2gec[1] A NCAP_IBVG Nucleocapsid protein[138 aa] B 36.8
/41.3
19
/25
NCAP_IBVG Nucleocapsid protein
5epw[2] B NCAP_CVHNL Nucleoprotein[110 aa] A 32.6
/40.0
43
/54
NCAP_CVHNL Nucleoprotein
2ge7[10] B NCAP_IBVG Nucleocapsid protein[108 aa] A 35.1
/30.1
57
/59
NCAP_IBVG Nucleocapsid protein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.
PRECIPITANT
422 pdb_id contact mol homologue
a3 description a4 identity[%]5 Ncon6 description
7f2b[2] C PO4
PHOSPHATE ION[5 atoms]
A 100.0
/95.3
1
/1
NCAP_SARS2 Nucleoprotein
7f2b[3] D PO4
PHOSPHATE ION[5 atoms]
A 100.0
/95.3
2
/2
NCAP_SARS2 Nucleoprotein
7f2b[1] F PO4
PHOSPHATE ION[5 atoms]
B 80.0
/95.3
5
/5
NCAP_SARS2 Nucleoprotein
7f2b[1] H PO4
PHOSPHATE ION[5 atoms]
B 100.0
/95.3
3
/3
NCAP_SARS2 Nucleoprotein
7f2e[4] M PO4
PHOSPHATE ION[5 atoms]
G 100.0
/95.3
3
/3
NCAP_SARS2 Nucleoprotein
7f2e[4] M PO4
PHOSPHATE ION[5 atoms]
H 100.0
/95.3
1
/1
NCAP_SARS2 Nucleoprotein
7xwx[3] I PO4
PHOSPHATE ION[5 atoms]
A 100.0
/96.0
2
/2
NCAP_SARS2 Nucleoprotein
2gib[5] C SO4
SULFATE ION[5 atoms]
A 100.0
/100.0
2
/2
NCAP_CVHSA Nucleocapsid protein
5n4k[4] D SO4
SULFATE ION[5 atoms]
A 66.7
/45.5
3
/3
NCAP_CVHNL Nucleoprotein
5n4k[1] I SO4
SULFATE ION[5 atoms]
A 50.0
/45.5
2
/2
NCAP_CVHNL Nucleoprotein
5n4k[7] J SO4
SULFATE ION[5 atoms]
A 50.0
/45.5
2
/4
NCAP_CVHNL Nucleoprotein
5n4k[2] K SO4
SULFATE ION[5 atoms]
A 0.0
/45.5
2
/2
NCAP_CVHNL Nucleoprotein
6wzq[1] F SO4
SULFATE ION[5 atoms]
A 100.0
/95.6
1
/1
NCAP_SARS2 Nucleoprotein
6wzq[3] G SO4
SULFATE ION[5 atoms]
B 100.0
/95.6
1
/1
NCAP_SARS2 Nucleoprotein
6wzq[1] I SO4
SULFATE ION[5 atoms]
C 100.0
/95.7
3
/3
NCAP_SARS2 Nucleoprotein
7n0r[1] F SO4
SULFATE ION[5 atoms]
B 100.0
/92.1
2
/2
NCAP_SARS2 Nucleoprotein
7n0r[1] G SO4
SULFATE ION[5 atoms]
B 100.0
/92.1
4
/4
NCAP_SARS2 Nucleoprotein
6g13[1] G PEG
DI(HYDROXYETHYL)ETHER[7 atoms]
A 80.0
/54.3
5
/5
A0A0D3MU51_9BETC Nucleoprotein
7c22[1] F PEG
DI(HYDROXYETHYL)ETHER[7 atoms]
A 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7de1[1] C PEG
DI(HYDROXYETHYL)ETHER[7 atoms]
B 100.0
/95.7
5
/5
NCAP_SARS2 Nucleoprotein
7de1[2] D PEG
DI(HYDROXYETHYL)ETHER[7 atoms]
B 100.0
/95.7
2
/2
NCAP_SARS2 Nucleoprotein
7uxz[2] H PEG
DI(HYDROXYETHYL)ETHER[7 atoms]
A 100.0
/95.4
4
/4
NCAP_SARS2 Nucleoprotein
7uxz[1] H PEG
DI(HYDROXYETHYL)ETHER[7 atoms]
B 100.0
/95.4
1
/1
NCAP_SARS2 Nucleoprotein
7xxk[1] G SCN
THIOCYANATE ION[3 atoms]
A 100.0
/95.4
5
/5
NCAP_SARS2 Nucleoprotein
6vyo[6] E MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms]
A 100.0
/91.9
5
/5
NCAP_SARS2 Nucleoprotein
6vyo[6] G MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms]
A 100.0
/91.9
3
/3
NCAP_SARS2 Nucleoprotein
7xx1[4] G MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms]
A 100.0
/92.0
4
/4
NCAP_SARS2 Nucleoprotein
7xx1[4] L MES
2-(N-MORPHOLINO)-ETHANESULFONIC ACID[12 atoms]
A 100.0
/92.0
1
/1
NCAP_SARS2 Nucleoprotein
4ud1[2] I GOL
GLYCEROL[6 atoms]
B 33.3
/58.3
3
/3
T2B9R0_9BETC N PROTEIN
4ud1[5] M GOL
GLYCEROL[6 atoms]
D 0.0
/60.7
3
/3
T2B9R0_9BETC N PROTEIN
6vyo[3] K GOL
GLYCEROL[6 atoms]
B 100.0
/92.0
3
/3
NCAP_SARS2 Nucleoprotein
6vyo[2] P GOL
GLYCEROL[6 atoms]
C 83.3
/92.0
6
/6
NCAP_SARS2 Nucleoprotein
7o36[1] F GOL
GLYCEROL[6 atoms]
B 100.0
/95.4
9
/9
NCAP_SARS2 Nucleoprotein
7uxx[1] G GOL
GLYCEROL[6 atoms]
A 100.0
/95.4
4
/4
NCAP_SARS2 Nucleoprotein
7uxx[17] G GOL
GLYCEROL[6 atoms]
C 100.0
/95.4
2
/2
NCAP_SARS2 Nucleoprotein
7uxx[3] J GOL
GLYCEROL[6 atoms]
F 75.0
/95.5
4
/4
NCAP_SARS2 Nucleoprotein
7xwz[1] I GOL
GLYCEROL[6 atoms]
B 66.7
/91.7
6
/6
NCAP_SARS2 Nucleoprotein
7c22[2] E ACT
ACETATE ION[4 atoms]
A 100.0
/95.4
2
/2
NCAP_SARS2 Nucleoprotein
7c22[2] E ACT
ACETATE ION[4 atoms]
B 100.0
/95.6
1
/1
NCAP_SARS2 Nucleoprotein
7n0i[1] M ACT
ACETATE ION[4 atoms]
C 100.0
/95.8
3
/3
NCAP_SARS2 Nucleoprotein
7n0i[1] M ACT
ACETATE ION[4 atoms]
D 100.0
/95.8
2
/2
NCAP_SARS2 Nucleoprotein
7n0i[1] O ACT
ACETATE ION[4 atoms]
L 100.0
/95.8
2
/2
NCAP_SARS2 Nucleoprotein
7uxx[1] I ACT
ACETATE ION[4 atoms]
B 100.0
/95.4
3
/3
NCAP_SARS2 Nucleoprotein
7uxx[1] I ACT
ACETATE ION[4 atoms]
D 100.0
/95.4
2
/2
NCAP_SARS2 Nucleoprotein
7vnu[1] E ACT
ACETATE ION[4 atoms]
C 100.0
/92.1
3
/3
NCAP_SARS2 Nucleoprotein
2ofz[1] B EDO
1,2-ETHANEDIOL[4 atoms]
A 100.0
/100.0
2
/2
NCAP_CVHSA Nucleocapsid protein
7n3c[1] M EDO
1,2-ETHANEDIOL[4 atoms]
C 100.0
/92.1
1
/1
NCAP_SARS2 Nucleoprotein
7n3c[1] R EDO
1,2-ETHANEDIOL[4 atoms]
C 100.0
/92.1
3
/3
NCAP_SARS2 Nucleoprotein
7n3c[1] S EDO
1,2-ETHANEDIOL[4 atoms]
C 100.0
/92.1
5
/5
NCAP_SARS2 Nucleoprotein
7n3d[1] K EDO
1,2-ETHANEDIOL[4 atoms]
C 100.0
/92.7
2
/2
NCAP_SARS2 Nucleoprotein
7n3d[2] L EDO
1,2-ETHANEDIOL[4 atoms]
C 80.0
/92.7
5
/5
NCAP_SARS2 Nucleoprotein
7n3d[1] M EDO
1,2-ETHANEDIOL[4 atoms]
C 100.0
/92.7
5
/5
NCAP_SARS2 Nucleoprotein
7n3d[1] N EDO
1,2-ETHANEDIOL[4 atoms]
C 66.7
/92.7
3
/3
NCAP_SARS2 Nucleoprotein
7str[1] D EDO
1,2-ETHANEDIOL[4 atoms]
C 100.0
/92.1
1
/1
NCAP_SARS2 Nucleoprotein
7str[1] G EDO
1,2-ETHANEDIOL[4 atoms]
C 80.0
/92.1
5
/5
NCAP_SARS2 Nucleoprotein
7xwz[2] G EDO
1,2-ETHANEDIOL[4 atoms]
A 66.7
/92.0
3
/3
NCAP_SARS2 Nucleoprotein
4ud1[2] H IMD
IMIDAZOLE[5 atoms]
B 66.7
/58.3
3
/3
T2B9R0_9BETC N PROTEIN
6g13[1] E TMO
trimethylamine oxide[5 atoms]
A 0.0
/54.3
1
/1
A0A0D3MU51_9BETC Nucleoprotein
6g13[3] F TMO
trimethylamine oxide[5 atoms]
A 66.7
/54.3
3
/3
A0A0D3MU51_9BETC Nucleoprotein
4j3k[1] B TRS
2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL[8 atoms]
A 44.4
/49.2
9
/9
Q6SA23_CVHOC Nucleoprotein
3.a3:asym_id for the contact molecule. 4.a4:asym_id for the template homologue. 5.identity[%]5:sequence identity between the query and the template homologue only for the contact residues. Number after the slash / is sequence identity for all the aligned region. 6.Ncon6:number of aligned contact residues for the query. Number after the slash / is number of contact residues in the template homologue.